Korean J Anesthesiol Search


Korean Journal of Anesthesiology 2009;57(2):161-164.
DOI: https://doi.org/10.4097/kjae.2009.57.2.161   
The effect of intraoperative remifentanil infusion on analgesic requirements after laparoscopic cholecystectomy.
Jae Jun Lee, Sung Jun Hong, Joo Sung Kim, Sung Mi Hwang, So Young Lim, Soo Kyung Lee
Department of Anesthesiology and Pain Medicine, Hallym University, College of Medicine, Chuncheon, Korea. h70sm@hallym.or.kr
This study was designed to evaluate the effect of intraoperative remifentanil infusion on postoperative analgesics requirements after laparoscopic cholecystectomy.
One hundred adult patients scheduled for elective laparoscopic cholecystectomy were enrolled. Patients were randomly allocated to 2 groups to receive sevoflurane with remifentanil infusion (Group R) or not (group C). Sevoflurane concentration and remifentanil dose were adjusted to maintain BIS 40-60 and blood pressure within 20% of the preoperative value, respectively. We assessed the pain intensity by using the four-point verbal rating scale (VRS) (0 = no pain. 1 = slight pain, 2 = moderate pain, 3 = intense or severe pain) at 15 min intervals for 1 hour in recovery room and then at 3-h intervals for 24 h in surgical ward. The analgesic medication was given when VRS score was > or =2 or patients requested it. RESULTS: There were no differences between the two groups with respect to the requirements for postoperative analgesics in recovery room and surgical ward. CONCLUSIONS: Continuous remifentanil infusion (0.09 +/- 0.05 ug/kg/min) during laparoscopic cholecystectomy does not cause hyperalgesia and more analgesic requirements.
Key Words: Laparoscopic cholecystectomy; Pain; Remifentanil


Browse all articles >

Editorial Office
101-3503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-792-5128    Fax: +82-2-792-4089    E-mail: journal@anesthesia.or.kr                

Copyright © 2024 by Korean Society of Anesthesiologists.

Developed in M2PI

Close layer
prev next